Commercially Available for Clinical Research
The richness of our data platform allows us to algorithmically extract many features and biomarkers of neural state and health that can be used across applications including neuro-health, disease management, and drug discovery — both in the clinic and more importantly, in the home.
Submit inquiry to become a research partner
The neural signals we collect from the ear is just the beginning. With a mobile app that enables in-depth cognitive assessments, self-reports, performance monitoring, and medication tracking, we see users in multiple dimensions.
Data about your brain needs to be handled with great care. Privacy and security are, and always will be, a top priority organization-wide. All data collected by NextSense is HIPAA compliant, in accordance with GCP guidelines, and is end-to-end encrypted. We are 21 CFR Part 11 ready, and are regularly audited for NIST Cybersecurity Framework adherence.
In addition to general longitudinal monitoring and alerting capabilities, we offer condition-specific packages that users can subscribe to (and that researchers can leverage in their work).
Replace with: Many strokes are preceded by Transient Ischemic Attack—or TIAs—a temporary blockage of blood flow to the brain. TIAs can last only a few minutes. As a result, they often go ignored.
NextSense can alert people who are experiencing a TIA. If these people see a medical professional, they can reduce their chance of having a full blown stroke by 90%.
Individuals with epilepsy often feel like they’re at the mercy of their next seizure. Regardless of frequency, they’re plagued with the fear that they’ll have an attack at an important event like a wedding or that they’ll lose their driving privileges if they have a seizure while on the road.
Currently, there is no continuous remote monitoring and care solution on the market for epilepsy. Our biosensing earbuds can provide physicians with important information about how a patient is responding to a particular treatment in real time, enabling more effective medication titration for maximal benefit while minimizing side effects.
is the estimated healthcare cost of epilepsy treatment in the US per year.
of adults with epilepsy experience resistance to drug treatment.
people in the United States experience a stroke each year.
of all strokes were preceded by transient attack (a TIA, or temporary blockage).
The shape of a concussion’s effects on the brain over time can vary significantly. We are currently working on both detection algorithms as well as real-time insights for medium and long-term concussion management for sports-related concussions as well those caused as a secondary effect of diseases like Parkinsons.
Tracking sleep EEG longitudinally may provide insight into how the brain is aging. We aim to identify early biomarkers of Alzheimer’s disease and other neurodegenerative conditions prior to onset of clinical symptoms, which could eventually lead to preventive intervention.
As part of our R&D, we’re developing algorithms for seizure forecasting. This may provide patients with a daily seizure risk score, enabling them to modify certain behaviors and/or take an additional dose of medication.
